Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
Based on Analyst Price Targets
Innovating Pharma Commercialization And Efficiency To Propel Revenue And Margins
US$259.92
FV
15.4% undervalued intrinsic discount7.60%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative